Mrmed

  Tagrisso 80mg   is a medicine used for treatment of advanced non-small cell lung cancer (NSCLC). Non-small cell lung cancer is a disorder caused due to mutation of Epidermal Growth Factor Receptor EGFR T790M. It is the preferred choice of drug for an advanced level of cancer that has spread or is spreading to other parts of the body. Tagrisso uses a small molecule inhibitor of tyrosine kinase. So, it can also be used as an alternative treatment for patients who have stopped responding to earlier treatments with other tyrosine kinase inhibitors. The drug targets the mutant tumors that have the gene of L858R and exon 19 EGFR. It fights against the action of abnormal growth of the Epidermal Growth Factor Receptor EGFR T790M. Along with that it also prevents the lung cancer from relapsing after the removal of the tumor after the surgery.   Tagrisso is a very expensive drug. MrMed provides a Patient Assistance Program for the same, which is sponsored by the manufacturers. ...

  Introduction: Tagrisso 80mg  Tablet is a small molecule inhibitor of tyrosine kinase that is used for treating advanced Non-small cell lung cancer (NSCLC) caused due to mutation of Epidermal Growth Factor Receptor EFGR T790M. It is the preferred choice to treat advanced lung cancer that has started spreading to other parts of the body in patients who have failed to respond to other anti-cancer medications. Uses of Tagrisso 80mg Tablet: Treatment of Non-Small Cell Lung Cancer (NSCLC). To treat Advanced Non-Small Cell Lung Cancer, that has spread to other parts of the body that cannot be removed by surgery. Alternative treatment for patients who have stopped responding to earlier treatments with other tyrosine kinase inhibitors. How Tagrisso 80mg Tablet works:  Tagrisso 80mg Tablet targets the mutant of tumors that have the gene L858R and exon 19 EFGR. It acts against the abnormal growth of Epidermal Growth Factor Receptor EFGR T790M. It helps to shrink the cancer cells, ...